Sesn2 positively regulates Akt signaling and survival in human squamous cell carcinoma (SCC) and melanoma cells in response to UVB stress and chemotherapeutics, suggesting that Sesn2 may promote tumorigenesis and chemoresistance in SCC and melanoma [96]. Here, SESN2 is linked to squamous cell carcinoma.